| NE |
Noble Corp plc |
Eifler Robert W. |
Director
Officer
|
2026-02-12 |
F - D |
44,727 |
42.10 |
1,883,006.70 |
1,343,828 |
| MAS |
MASCO CORP /DE/ |
Eisman Heath M |
Officer
|
2026-02-12 |
A - A |
1,600 |
0.00 |
0.00 |
13,636 |
| (CALX) |
CALIX, INC |
Eleniak Shane Todd Marshall |
Officer
|
2026-02-12 |
A - A |
195,000 |
0.00 |
0.00 |
195,000 |
| ZION |
ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ |
Ellingsen Eric |
Officer
Other
|
2026-02-12 |
F - D |
803 |
60.19 |
48,332.57 |
38,496 |
| ZION |
ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ |
Ellingsen Eric |
Officer
Other
|
2026-02-12 |
A - A |
6,503 |
60.19 |
391,415.57 |
44,999 |
| IDXX |
IDEXX LABORATORIES INC /DE |
Emerson Andrew |
Officer
|
2026-02-12 |
A - A |
4,270 |
0.00 |
0.00 |
4,270 |
| IDXX |
IDEXX LABORATORIES INC /DE |
Emerson Andrew |
Officer
|
2026-02-12 |
A - A |
162 |
0.00 |
0.00 |
162 |
| IDXX |
IDEXX LABORATORIES INC /DE |
Emerson Andrew |
Officer
|
2026-02-12 |
A - A |
729 |
0.00 |
0.00 |
729 |
| IDXX |
IDEXX LABORATORIES INC /DE |
Emerson Andrew |
Officer
|
2026-02-12 |
A - A |
284 |
0.00 |
0.00 |
284 |
| IDXX |
IDEXX LABORATORIES INC /DE |
Emerson Andrew |
Officer
|
2026-02-12 |
M - D |
65 |
0.00 |
0.00 |
193 |
| ELVN |
Enliven Therapeutics, Inc. |
Garland J. Scott |
|
2026-02-12 |
A - A |
1,427 |
0.00 |
0.00 |
1,427 |
| ELVN |
Enliven Therapeutics, Inc. |
Kunkel Lori Anne |
|
2026-02-12 |
A - A |
17,126 |
0.00 |
0.00 |
17,126 |
| ELVN |
Enliven Therapeutics, Inc. |
Gupta Rishi |
|
2026-02-12 |
A - A |
33,989 |
0.00 |
0.00 |
33,989 |
| ELVN |
Enliven Therapeutics, Inc. |
Gupta Rishi |
|
2026-02-12 |
A - A |
1,580 |
0.00 |
0.00 |
1,580 |
| ELVN |
Enliven Therapeutics, Inc. |
Heyman Richard A. |
|
2026-02-12 |
A - A |
19,234 |
0.00 |
0.00 |
19,234 |
| ELVN |
Enliven Therapeutics, Inc. |
Bauer Jake |
|
2026-02-12 |
A - A |
17,126 |
0.00 |
0.00 |
17,126 |
| ELVN |
Enliven Therapeutics, Inc. |
Collins Helen Louise |
|
2026-02-12 |
A - A |
25,000 |
0.00 |
0.00 |
25,000 |
| ELVN |
Enliven Therapeutics, Inc. |
Collins Helen Louise |
|
2026-02-12 |
A - A |
150,000 |
0.00 |
0.00 |
150,000 |
| ELVN |
Enliven Therapeutics, Inc. |
Ballal Rahul D. |
|
2026-02-12 |
A - A |
17,126 |
0.00 |
0.00 |
17,126 |
| ELVN |
Enliven Therapeutics, Inc. |
Derynck Mika K |
|
2026-02-12 |
A - A |
17,126 |
0.00 |
0.00 |
17,126 |
| ELVN |
Enliven Therapeutics, Inc. |
Hohl Benjamin |
|
2026-02-12 |
A - A |
25,000 |
0.00 |
0.00 |
61,000 |
| ELVN |
Enliven Therapeutics, Inc. |
Hohl Benjamin |
|
2026-02-12 |
A - A |
150,000 |
0.00 |
0.00 |
150,000 |
| ELVN |
Enliven Therapeutics, Inc. |
Lyssikatos Joseph P |
|
2026-02-12 |
A - A |
18,750 |
0.00 |
0.00 |
18,750 |
| ELVN |
Enliven Therapeutics, Inc. |
Lyssikatos Joseph P |
|
2026-02-12 |
A - A |
112,500 |
0.00 |
0.00 |
112,500 |
| ELVN |
Enliven Therapeutics, Inc. |
Patel Anish |
|
2026-02-12 |
A - A |
20,000 |
0.00 |
0.00 |
20,000 |